TNFR2 Sex Differences and EAE
TNFR2 性别差异和 EAE
基本信息
- 批准号:10532717
- 负责人:
- 金额:$ 37.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-01 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:ATF6 geneAgonistCell DeathCellsCentral Nervous SystemCoupledDataDiseaseDisease ProgressionExperimental Autoimmune EncephalomyelitisFemaleGenesGeneticGoalsGonadal Steroid HormonesImmune responseIn VitroInflammationInflammatory ResponseKnockout MiceLigationLinkMediatingMediatorMotorMultiple SclerosisMusMyelinNatural regenerationNerve DegenerationNeuroimmuneNeuroimmune systemNeurologicNeuronsOligodendrogliaPathologyPathway interactionsPhysiologicalPredispositionProcessProtein BiosynthesisProteinsPublishingQuality ControlReceptors, Tumor Necrosis Factor, Type IIRecovery of FunctionRegenerative responseRoleSeriesSex BiasSex ChromosomesSex DifferencesSignal InductionSignal TransductionStressTNFRSF1B geneTestingTherapeuticTherapeutic EffectWorkXBP1 geneburden of illnesshormonal signalsimprovedin vivomalemotor disordermotor function improvementmotor impairmentmotor recoveryneuroinflammationneuropathologynovelpainful neuropathypharmacologicprogramsremyelinationrepairedresponsesextranscriptome sequencing
项目摘要
Abstract
The susceptibility to Multiple Sclerosis (MS) is believed to be due in part to neuroinflammation
and disease burden linked to neurodegeneration. It is well established that females have a more robust
immune response than males however, neurodegeneration and disease progression are more sever in
males. Thus, in the context of MS, this raises an intriguing question. Do females, by virtue of having a
more robust inflammatory responses, have endogenous protection/repair mechanisms to protect the
central nervous system (CNS) from inflammation induced pathology, that males do not have or that are
not as effective in males? This proposal is based upon extensive preliminary and published data
demonstrating that tmTNF/TNFR2 signaling in females, but not males, significantly improves motor
function and reduces neuropathology in EAE by activating endogenous repair programs in neurons and
oligodendrocytes. Based upon these and other results, our first experimental goal is to interrogate sex
differences in tmTNF/TNFR2 induced improvements in motor function and neuropathology. Further, we
have very novel pharmacological and genetic data that ligation of TNFR2 on both neurons and
oligodendrocytes induce regenerative responses, through IRE1-dependent mechanisms. Based upon
these and additional data our second experimental goal is to investigate the intersection between
TNFR2/IRE1 signaling and to determine if the therapeutic effects of TNFR2 activation are dependent
upon IRE1 activation. These goals will be tested in the following aims:
Specific Aim 1: Investigate the sex-specific effects of tmTNF/TNFR2 signaling in the improvement of
motor function and neuropathology.
A) We will investigate the role of sex hormones in tmTNF/TNFR2 signaling in the improvement of motor
function and neuropathology in male and female mice.
B) We will investigate the role of sex chromosomes in tmTNF/TNFR2 signaling in the improvement of motor
function and neuropathology in male and female mice.
Specific Aim 2: Investigate TNFR2 induced endogenous repair mechanisms in male and female mice.
A) We will interrogate TNFR2 induced endogenous repair mechanisms oligodendrocytes and determine if
they are required for motor recovery in females.
B) We will interrogate TNFR2 induced endogenous repair mechanisms neurons and determine if they are
required for motor recovery in females, in vivo and in vitro.
摘要
多发性硬化(MS)的易感性被认为部分是由于神经炎症
和与神经退化有关的疾病负担。众所周知,女性有更强大的
然而,与男性相比,
男性。因此,在MS的背景下,这提出了一个有趣的问题。女性,由于拥有一个
更强的炎症反应,具有内源性保护/修复机制,以保护
中枢神经系统(CNS)炎症诱导的病理,男性没有或
对男性没有效果吗该提案基于广泛的初步和已发布的数据
这表明女性而非男性中的tmTNF/TNFR 2信号传导显著改善了运动功能,
通过激活神经元中的内源性修复程序,
少突胶质细胞基于这些和其他结果,我们的第一个实验目标是询问性
tmTNF/TNFR 2的差异诱导运动功能和神经病理学的改善。我们还
具有非常新颖的药理学和遗传学数据,
少突胶质细胞通过IRE 1依赖性机制诱导再生反应。基于
我们的第二个实验目标是研究这些数据和其他数据之间的交叉点,
TNFR 2/IRE 1信号传导,并确定TNFR 2激活的治疗作用是否依赖于
在IRE 1激活后。这些目标将在以下目标中得到检验:
具体目的1:研究tmTNF/TNFR 2信号传导在改善肿瘤细胞增殖中的性别特异性作用。
运动功能和神经病理学。
A)我们将研究性激素在tmTNF/TNFR 2信号传导中在改善运动神经功能中的作用。
功能和神经病理学。
B)我们将研究性染色体在tmTNF/TNFR 2信号转导中在改善运动神经功能中的作用。
功能和神经病理学。
具体目的2:研究TNFR 2诱导的雄性和雌性小鼠内源性修复机制。
A)我们将询问TNFR 2诱导的内源性修复机制少突胶质细胞,并确定是否
它们是女性运动恢复所必需的。
B)我们将询问TNFR 2诱导的内源性修复机制神经元,并确定它们是否是内源性修复机制神经元。
在雌性动物体内和体外运动恢复所需的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Roland Bethea其他文献
John Roland Bethea的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Roland Bethea', 18)}}的其他基金
SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
- 批准号:
10207806 - 财政年份:2019
- 资助金额:
$ 37.88万 - 项目类别:
SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
- 批准号:
10019418 - 财政年份:2019
- 资助金额:
$ 37.88万 - 项目类别:
SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
- 批准号:
10441446 - 财政年份:2019
- 资助金额:
$ 37.88万 - 项目类别:
SCI-induced deficits in antiviral immunity: The role of sTNF.
SCI 引起的抗病毒免疫缺陷:sTNF 的作用。
- 批准号:
10657427 - 财政年份:2019
- 资助金额:
$ 37.88万 - 项目类别:
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
可溶性 TNFa 在脊髓损伤后自主神经反射异常发展中的作用
- 批准号:
10386794 - 财政年份:2018
- 资助金额:
$ 37.88万 - 项目类别:
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
可溶性 TNFa 在脊髓损伤后自主神经反射异常发展中的作用
- 批准号:
9902562 - 财政年份:2018
- 资助金额:
$ 37.88万 - 项目类别:
Enhancing supraspinal plasticity to improve functional recovery after SCI
增强脊髓上可塑性以改善 SCI 后的功能恢复
- 批准号:
9976601 - 财政年份:2017
- 资助金额:
$ 37.88万 - 项目类别:
Enhancing supraspinal plasticity to improve functional recovery after SCI
增强脊髓上可塑性以改善 SCI 后的功能恢复
- 批准号:
9193741 - 财政年份:2016
- 资助金额:
$ 37.88万 - 项目类别:
Astrocytes Play a Critical Role in the Pathology of EAE
星形胶质细胞在 EAE 病理学中发挥关键作用
- 批准号:
8824782 - 财政年份:2009
- 资助金额:
$ 37.88万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 37.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 37.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)